Statement 3.2

  • Section 3

"Medicines that require manufacture or compounding must be produced by a hospital pharmacy, or outsourced under the responsibility of the hospital pharmacist."

What does it mean for patients? Injectable mixtures are prone to contamination. For patients especially neonatal and paediatric, this can have serious consequences. The pharmacy should therefore develop services to improve the safety of such injectable mixtures.

What does it mean for healthcare professionals? Preparing mixtures that are to be injected are at an increased risk to contamination, if not properly prepared. Other healthcare professionals on the ward do not have access to the facilities of the hospital pharmacies. Thus centralised services in the pharmacy can support healthcare professionals by improving the safety of such preparations.

What does it mean for Hospital Pharmacists? Hospital pharmacists should make a register of preparations that are made on the ward.  Hospital pharmacists should check the capacity of their staff and facilities in order to reconstitute medication. Hospital pharmacists should aim to centralise aseptic preparations by offering Good Practice for the preparation of medicinal products based services. 

Resources